November 04, 2025

Get In Touch

Subcutaneous ICD Reduces Lead-Related Complications Without Compromising Effectiveness Of ICD Shocks

Implantable cardioverter defibrillators (ICDs) improve survival in patients at risk for cardiac arrest, but are associated with intravascular lead-related complications.
Researchers have found in a randomized multicenter ATLAS trial that Subcutaneous implantable cardioverter defibrillators are associated with 92 percent reduction in lead-related complications typical in patients with ICDs.
The trial conducted on more than 500 persons revealed that subcutaneous implantable cardioverter defibrillators (S-ICDs) reduce perioperative, lead-related complications without significantly compromising the effectiveness of ICD shocks. However they were associated with more early postoperative pain and a trend for more inappropriate shocks.

The study is published in Annals of Internal Medicine.
ICDs improve survival in patients at risk for cardiac arrest but are associated with intravascular lead-related complications. The S-ICD, with no intravascular components, was developed to minimize lead-related complications.
Researchers from McMaster University conducted a randomized multicenter trial of 544 persons with a primary or secondary prevention indication for an ICD. The authors found that S-ICD usage demonstrated a 92 percent reduction of lead-related complications and prevented most lead-related perioperative complications, including myocardial perforation, which can lead to death. They also reported a modest reduction in system reliability with the S-ICD, specifically a trend toward more inappropriate shocks. After a mean follow-up of 2.5 years, there was a nonsignificant 22 percent reduction in the need for surgical ICD revision with the S-ICD and ongoing, longer-term follow-up of ATLAS participants will evaluate the effect that the S-ICD will have on chronic ICD performance and the need for ICD reoperation.
Reference:
Jeff S. Healey, Andrew D. Krahn, Jamil Bashir, Guy Amit, François Philippon, William F. McIntyre, Bernice Tsang, Jacqueline Joza, Derek V. Exner, David H. Birnie, Mouhannad Sadek, Darryl P. Leong, Markus Sikkel, Victoria Korley, John L. Sapp, Jean-Francois Roux, Shun Fu Lee, Gloria Wong, Angie Djuric, Danna Spears, Sandra Carroll, Eugene Crystal, Tom Hruczkowski, Stuart J. Connolly, and Blandine Mondesert, https://doi.org/10.7326/M22-1566

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!